Koi Herpes Vaccine Update


 

TIDMHML 
 
RNS Number : 0546O 
Henderson Morley PLC 
02 March 2009 
 
2 March 2009 
 
HENDERSON MORLEY PLC 
(AIM: HML) 
("Henderson Morley" or "the Company") 
 
Koi Herpes Vaccine update 
 
Henderson Morley plc, the AIM quoted biotechnology company, is pleased to 
announce the commencement of the next phase of studies to examine the efficacy 
of the Koi Herpes Vaccine candidates. The studies will be examining several 
advanced formulations of vaccine, which include several new adjuvant candidates 
(compounds added to the vaccine to improve immune responses). 
 
The studies, which are being completed by a sub-contract facility, will be 
examining three different vaccine formulations, and a combination of five 
different adjuvants, making ten study groups in total. 
 
The serological studies that are a crucial and important part of the vaccine 
development process (to enable assessment of immune responses) have been further 
optimised and validated to support the study. 
 
It is anticipated that the results of this study will be available by July 2009, 
and the results will be submitted to Schering Plough Animal health under the 
terms of the collaborative research and option agreement. 
 
 
 
=--ENDS--- 
 
 
ENQUIRIES: 
 
HENDERSON MORLEY PLC                                            0121 442 4600 
Andrew Knight, Chairman 
BISHOPSGATE COMMUNICATIONS LTD                         0207 562 3350 
 (Public 
Relations) 
 Maxine Barnes 
 Nick Rome 
 
 
BREWIN DOLPHIN INVESTMENT BANKING                        0113 241 0126 
(Nominated Adviser) 
Neil Baldwin 
 
HYBRIDAN LLP                                                            0203 159 
5085 
(Broker) 
Claire Noyce/Stephen Austin 
 
 
 
Notes to Editors: 
 
Henderson Morley was founded in 1996 with the objective of developing its anti 
viral application (Ionic Contra Viral Therapy (ICVT). ICVT is the Lead Platform 
and has been developed in-house and HML wholly owns the patent IPR. 
 
Further information on Henderson Morley plc can be accessed through the 
Company's website at www.henderson-morley.com 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 STREDLFLKLBEBBD

Henderson Mrly. (LSE:HML)
過去株価チャート
から 6 2024 まで 7 2024